Abstract
Ecoinfectomics is the ecological study of infectomes and explores symbiotic solutions to microbial infections. The most fundamental issue in ecological infectomics is how to transform situations of potential conflict (pathogenesis or Pat) into cooperation (symbiosis or Sym) by dissecting the dynamic Sym-Pat duality in microbial infections and developing symbiotic agents (symbiotics) that favor a healthy symbiosis. Symbiotics are defined as products that are beneficial to the symbiotic ecology of the super-organisms consisting of microbes and their human hosts. These include microbial (e.g., probiotic bacteria and phages) and nonmicrobial agents (e.g., prebiotics). Probiotics have been proposed as a promising way to prevent microbial infection in neonates. It has been shown that probiotics could be useful to correct ecological disorders in human intestinal microbiota associated with neonatal sepsis and meningitis, and might play a protective role in excluding pathogens from the intestine and preventing infections. Compared with commonly used antibiotics, a great advantage of phages is their narrow host range. A rational basis has been provided for the discovery and development of phage-based symbiotics that only kill pathogens but do not disturb benign microbes in normal microbiota. The systems biology study of ecoimmunity or ecoimmunome (ecoimmunomics), which is most closely related to ecoinfectomics, may provide alternative ecological strategies toward clinical challenges in infectious diseases. We propose that the balance between exosymbiosis (e.g, microbiota) and endosymbiosis (e.g., mitochondria) is essential for ecoimmunity and that the exo-endo Sym imbalance plays an important role in the pathogenesis of infectious diseases, including HIV/AIDS. Correction of disorders of the ecoimmunity in patients with AIDS may lead to a rational control of HIV infection. Holistic and integrative studies of ecoinfectomes, ecoimmunomes, and microbiome are important for our understanding of microbial pathogenesis and the development of symbiotic solutions to infectious diseases.
Keywords: Ecoimmunome, ecoimmunomics, ecoinfectome, ecoinfectomics, ecology, exo-endo sym balance, phage therapy, probiotics symbiotics.
Anti-Infective Agents
Title:Ecological Infectomics (Ecoinfectomics): Symbiotic Solutions to Microbial Infections
Volume: 11 Issue: 2
Author(s): Sheng-He Huang, Suoqin Tang, Tao Bo, Hongwei Xia and Ambrose Jong
Affiliation:
Keywords: Ecoimmunome, ecoimmunomics, ecoinfectome, ecoinfectomics, ecology, exo-endo sym balance, phage therapy, probiotics symbiotics.
Abstract: Ecoinfectomics is the ecological study of infectomes and explores symbiotic solutions to microbial infections. The most fundamental issue in ecological infectomics is how to transform situations of potential conflict (pathogenesis or Pat) into cooperation (symbiosis or Sym) by dissecting the dynamic Sym-Pat duality in microbial infections and developing symbiotic agents (symbiotics) that favor a healthy symbiosis. Symbiotics are defined as products that are beneficial to the symbiotic ecology of the super-organisms consisting of microbes and their human hosts. These include microbial (e.g., probiotic bacteria and phages) and nonmicrobial agents (e.g., prebiotics). Probiotics have been proposed as a promising way to prevent microbial infection in neonates. It has been shown that probiotics could be useful to correct ecological disorders in human intestinal microbiota associated with neonatal sepsis and meningitis, and might play a protective role in excluding pathogens from the intestine and preventing infections. Compared with commonly used antibiotics, a great advantage of phages is their narrow host range. A rational basis has been provided for the discovery and development of phage-based symbiotics that only kill pathogens but do not disturb benign microbes in normal microbiota. The systems biology study of ecoimmunity or ecoimmunome (ecoimmunomics), which is most closely related to ecoinfectomics, may provide alternative ecological strategies toward clinical challenges in infectious diseases. We propose that the balance between exosymbiosis (e.g, microbiota) and endosymbiosis (e.g., mitochondria) is essential for ecoimmunity and that the exo-endo Sym imbalance plays an important role in the pathogenesis of infectious diseases, including HIV/AIDS. Correction of disorders of the ecoimmunity in patients with AIDS may lead to a rational control of HIV infection. Holistic and integrative studies of ecoinfectomes, ecoimmunomes, and microbiome are important for our understanding of microbial pathogenesis and the development of symbiotic solutions to infectious diseases.
Export Options
About this article
Cite this article as:
Huang Sheng-He, Tang Suoqin, Bo Tao, Xia Hongwei and Jong Ambrose, Ecological Infectomics (Ecoinfectomics): Symbiotic Solutions to Microbial Infections, Anti-Infective Agents 2013; 11 (2) . https://dx.doi.org/10.2174/2211352511311020002
DOI https://dx.doi.org/10.2174/2211352511311020002 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Lassa Virus Genome
Current Genomics Nanoemulsion: A Novel Eon in Cancer Chemotherapy
Mini-Reviews in Medicinal Chemistry Effective Separation and Simultaneous Detection of Ceftriaxone Sodium and Levofloxacin in Human Urine by Capillary Zone Electrophoresis
Current Analytical Chemistry Intestinal Parasite Infestation in HIV Infected Patients
Current HIV Research Molecular Targets of Tannic Acid in Alzheimer's Disease
Current Alzheimer Research A PPARdelta Agonist Reduces Amyloid Burden and Brain Inflammation in a Transgenic Mouse Model of Alzheimers Disease
Current Alzheimer Research Clinical Characteristics of Behcet’s Disease in 453 Egyptian Patients Suffering from Uveitis with Gender Comparison
Current Rheumatology Reviews Respiratory Syncytial Virus (RSV) Prevention and Treatment: Past, Present, and Future
Cardiovascular & Hematological Agents in Medicinal Chemistry Biology of gama delta T Cells in Tuberculosis and Malaria
Current Molecular Medicine Antimicrobial Drug Interactions in the Critically Ill Patients
Current Clinical Pharmacology Advances in the Knowledge and Clinical Applications of Lactic Acid Bacteria as Probiotics in the Urogenital Tract
Current Women`s Health Reviews Organic Lesions in the Brain MRI of Children with Febrile Seizure
Current Medical Imaging Association of Genetic Variation with Pneumonia
Current Respiratory Medicine Reviews Advances in the Immune Pathogenesis and Treatment of Multiple Sclerosis
Central Nervous System Agents in Medicinal Chemistry Mixed Connective Tissue Disease (MCTD) – A Coming of Age
Current Rheumatology Reviews Predictive and Prognostic Value of Ascitic Fluid Mannose Binding Lectin in Patients with Spontaneous Bacterial Peritonitis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Aminoglycoside-Induced Ototoxicity
Current Pharmaceutical Design Can Apolipoproteins and Complement Factors be Biomarkers of Alzheimer’s Disease?
Current Alzheimer Research Melatonin Treatment Enhances Aβ Lymphatic Clearance in a Transgenic Mouse Model of Amyloidosis
Current Alzheimer Research Ectonucleotidases and Nucleotide/Nucleoside Transporters as Pharmacological Targets for Neurological Disorders
CNS & Neurological Disorders - Drug Targets